Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Anna K. Nowak

1-50 of 171 results

View this query on the Wikidata Query Service
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

scientific article published on January 1, 2016
Mesothelin-family proteins and diagnosis of mesothelioma

scientific article published in The Lancet
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

scientific article published in May 2003
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

scientific article published on 01 February 2004
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung C

scientific article published on December 24, 2015
Systemic therapy for advanced hepatocellular carcinoma: a review.

scientific article published on July 2004
Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.

scientific article
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

scientific article published on 17 July 2017
Targeting Aggressive Cancer Stem Cells in Glioblastoma

scientific article
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

scientific article published on 4 December 2008
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

scientific article published on 18 August 2009
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity

scientific article
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma

scientific article
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

scientific article published on August 2002
Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

article
Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

scientific article published on 17 August 2007
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth

scientific article
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial

scientific article published in July 2007
Combined chemoimmunotherapy of solid tumours: improving vaccines?

scientific article published on 15 August 2006
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

scientific article
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

scientific article
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

scientific article published on 6 January 2017
The information and support needs of patients diagnosed with High Grade Glioma

scientific article published on 16 September 2009
Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

scientific article published on 21 December 2010
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters

scientific article published on 6 April 2010
Caring for someone with high-grade glioma: a time of rapid change for caregivers

scientific article
Soluble mesothelin-related protein--a blood test for mesothelioma

scientific article
Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

scientific article
Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

scientific article published on 11 September 2017
Diagnosing cancer in the bush: a mixed-methods study of symptom appraisal and help-seeking behaviour in people with cancer from rural Western Australia.

scientific article published on 30 January 2013
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

scientific article published on 23 September 2016
Chemotherapy and immunotherapy: mapping the road ahead.

scientific article published on 24 December 2015
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

scientific article
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma

scientific article
Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

scientific article
Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trial

scientific article
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

scientific article
The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer

scientific article published on August 1, 2012
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

scientific article published on 12 April 2013
A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma

scientific article published on 01 September 2012
The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer

scientific article published on 01 December 2009
Patient and caregiver perceptions of communication of prognosis in high grade glioma

scientific article published on 14 December 2010
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.

scientific article
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

scientific article
Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

scientific article published on 2 August 2011
A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit

article
Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

scientific article published on August 21, 2012
Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.

scientific article published on August 2009
Contribution of the immune system to the chemotherapeutic response.

scientific article published on 28 January 2011
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.

scientific article published on 15 December 2014

Paulina is supported by:

About Paulina

Help